Cancer Detection Rates of Systematic and Targeted Prostate Biopsies after Biparametric MRI

Table 2

Whole group pathology outcomes of systematic biopsy and targeted biopsy.

Targeted biopsy	Systematic biopsy			Total
	No cancer	Gleason 6	≥Gleason 7
Not performed	15	9	0	24
No cancer	22	6	1	29
Gleason 6	3	7	2	12
≥Gleason 7	2	1	14	17
Total	42	23	17	82

Pathology outcomes per patient for systematic biopsy and targeted MR/US fusion biopsy. The numbers in bold indicate patients with a pathology upgrade of clinical importance with systematic biopsy. The numbers in italics indicate patients with a pathology upgrade of clinical importance with targeted biopsy.